Delivery Order SPE2DB24D2013-SPE2DB26FCGQR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,833.56 to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, a pharmaceutical product. The contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizing firm fixed pricing with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.40 to AmerisourceBergen Drug Corp for Briviact 50mg tablets (60-count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $5,579.94 delivery order to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, valued at $2,602.93, with an ultimate completion date of October 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction under the agency's pharmaceutical procurement framework. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Briviact 100 mg tablets (60 count) with a ceiling value of $2,943.28. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for 60-tablet units of Briviact 100 mg tablets with a ceiling value of $6,386.97. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under the company's larger indefinite delivery contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg with a ceiling value of $1,068.57. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) valued at $1,929.44 under a firm fixed price contract. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside delivery order represents a small-value pharmaceutical transaction executed through open competition, with performance conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,165.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Briviact 100 mg tablets (60-count units). This is a non-set-aside, competitively awarded delivery order with performance in Conshohocken, Pennsylvania, scheduled for completion by June 20, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 50 mg tablets (60-count units) under a firm fixed-price contract valued at $2,538.23. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB26FCGQRDelivery Order
The Defense Logistics Agency awarded a $3,876.41 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, with an ultimate completion date of October 27, 2025. This non-set-aside contract was competitively awarded on October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply portfolio. This award is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company has demonstrated consistent capability in fulfilling federal medical procurement requirements through open competition, providing medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 10/24/25 |